Aditya Ullal

Aditya Ullal, MD is an Assistant Professor in the Department of Medicine at the University of California, San Francisco (UCSF) School of Medicine. He specializes in clinical outcomes and health services research focused on medication safety in inpatient settings, particularly examining outcomes related to gabapentin use. His clinical roles include teaching on the Moffit-Long Wards service and providing direct care as a hospitalist across multiple services, including Goldman Medicine, Mount Zion Hospitalist, and Mission Bay Consulting Services. He also serves in peri-operative medicine consult roles for Orthopedics and Neurosurgery.

Education:

• Stanford University School of Medicine, MD
• Stanford Internal Medicine Residency

Research Interests:

Dr. Ullal’s research emphasizes improving patient safety through analysis of medication-related adverse events in hospitalized adults. His current work focuses on gabapentin’s effects, leveraging large clinical registries to evaluate quality measures and treatment patterns in atrial fibrillation. His studies often intersect cardiology, public health, and healthcare policy to address disparities in care and medication outcomes.

Publications:

His peer-reviewed work spans cardiology topics like atrial fibrillation management, anticoagulation therapy, catheter ablation outcomes, and healthcare policy implications. Key themes include evaluating drug safety (e.g., amiodarone, digoxin), gender/racial disparities in treatment response, and cost-effectiveness of interventions. Recent studies highlight his focus on optimizing stroke prevention strategies and identifying silent atrial fibrillation in high-risk populations.

Grants & Advising:

No specific grants or student mentorship details are provided in the text. His clinical roles and research collaborations suggest involvement in institutional and collaborative projects, though explicit grant information is absent.

Labs/Teams:

Not explicitly mentioned, but his work aligns with UCSF’s broader initiatives in cardiovascular research and hospital medicine teams.